179 related articles for article (PubMed ID: 18441333)
21. Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies.
Sarapa N; Nickens DJ; Raber SR; Reynolds RR; Amantea MA
Clin Pharmacol Ther; 2008 Jan; 83(1):153-9. PubMed ID: 17581594
[TBL] [Abstract][Full Text] [Related]
22. Statistical characteristics of moxifloxacin-induced QTc effect.
Yan LK; Zhang J; Ng MJ; Dang Q
J Biopharm Stat; 2010 May; 20(3):497-507. PubMed ID: 20358432
[TBL] [Abstract][Full Text] [Related]
23. A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.
Abbas R; Hug BA; Leister C; Sonnichsen D
Int J Cancer; 2012 Aug; 131(3):E304-11. PubMed ID: 22065400
[TBL] [Abstract][Full Text] [Related]
24. Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested.
Zhang X; Silkey M; Schumacher M; Wang L; Raval H; Caulfield JP
J Clin Pharmacol; 2009 May; 49(5):534-9. PubMed ID: 19287043
[TBL] [Abstract][Full Text] [Related]
25. Improving the precision of QT measurements.
Darpo B; Fossa AA; Couderc JP; Zhou M; Schreyer A; Ticktin M; Zapesochny A
Cardiol J; 2011; 18(4):401-10. PubMed ID: 21769821
[TBL] [Abstract][Full Text] [Related]
26. Effect of intravenous zanamivir on cardiac repolarization.
Lou Y; Gan J; Peppercorn A; Gould E; Weller S; Piscitelli SC; Patel P
Pharmacotherapy; 2013 Jul; 33(7):701-9. PubMed ID: 23553534
[TBL] [Abstract][Full Text] [Related]
27. Effect of raltegravir on the pharmacokinetics of methadone.
Anderson MS; Mabalot Luk JA; Hanley WD; Jin B; Riesenberg RA; Wenning LA; Chodakewitz JA; Wagner JA; Iwamoto M
J Clin Pharmacol; 2010 Dec; 50(12):1461-6. PubMed ID: 20173085
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the effect of Naloxegol on cardiac repolarization: a randomized, placebo- and positive-controlled crossover thorough QT/QTc study in healthy volunteers.
Gottfridsson C; Carlson G; Lappalainen J; Sostek M
Clin Ther; 2013 Dec; 35(12):1876-83. PubMed ID: 24238792
[TBL] [Abstract][Full Text] [Related]
29. Single therapeutic and supratherapeutic doses of anacetrapib, a cholesteryl ester transfer protein inhibitor, do not prolong the QTcF interval in healthy volunteers.
Lauring B; Liu Y; Li XS; Larson P; Moreau A; Farmer HF; Johnson-Levonas AO; Wagner JA; Lai E
J Clin Pharmacol; 2014 Jul; 54(7):765-75. PubMed ID: 24615657
[TBL] [Abstract][Full Text] [Related]
30. A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation.
Mansbach RS; Ludington E; Rogowski R; Kittrelle JP; Jochelson P
Clin Ther; 2011 Jul; 33(7):851-62. PubMed ID: 21722958
[TBL] [Abstract][Full Text] [Related]
31. Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study.
Morganroth J; Gretler DD; Hollenbach SJ; Lambing JL; Sinha U
Expert Opin Pharmacother; 2013 Jan; 14(1):5-13. PubMed ID: 23216423
[TBL] [Abstract][Full Text] [Related]
32. Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study.
Malik M; van Gelderen EM; Lee JH; Kowalski DL; Yen M; Goldwater R; Mujais SK; Schaddelee MP; de Koning P; Kaibara A; Moy SS; Keirns JJ
Clin Pharmacol Ther; 2012 Dec; 92(6):696-706. PubMed ID: 23149929
[TBL] [Abstract][Full Text] [Related]
33. No effect of a single supratherapeutic dose of lersivirine, a next-generation nonnucleoside reverse transcriptase inhibitor, on corrected QT interval in healthy subjects.
Vourvahis M; Wang R; Ndongo MN; O'Gorman M; Tawadrous M
Antimicrob Agents Chemother; 2012 May; 56(5):2408-13. PubMed ID: 22371898
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
Wang Z; Grasela DM; Krishna G
Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
[TBL] [Abstract][Full Text] [Related]
35. Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects.
Ayalasomayajula S; Yeh CM; Vaidyanathan S; Flannery B; Dieterich HA; Howard D; Bedigian MP; Dole WP
J Clin Pharmacol; 2008 Jul; 48(7):799-811. PubMed ID: 18490495
[TBL] [Abstract][Full Text] [Related]
36. Single therapeutic and supratherapeutic doses of corifollitropin alfa, a sustained follicle stimulant, do not prolong the QTcF-interval in healthy postmenopausal volunteers.
de Kam PJ; van Kuijk JH; Zandvliet AS; Thomsen T
Int J Clin Pharmacol Ther; 2015 Sep; 53(9):772-82. PubMed ID: 26227099
[TBL] [Abstract][Full Text] [Related]
37. Comparison of manual and automated measurements of the QT interval in healthy volunteers: an analysis of five thorough QT studies.
Fosser C; Duczynski G; Agin M; Wicker P; Darpo B
Clin Pharmacol Ther; 2009 Nov; 86(5):503-6. PubMed ID: 19339965
[TBL] [Abstract][Full Text] [Related]
38. The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafil.
Fossa AA; Langdon G; Couderc JP; Zhou M; Darpo B; Wilson F; Wallis R; Davis JD
Clin Pharmacol Ther; 2011 Sep; 90(3):449-54. PubMed ID: 21814193
[TBL] [Abstract][Full Text] [Related]
39. Preladenant, a selective adenosine A₂A receptor antagonist, is not associated with QT/QTc prolongation.
Wang Z; Xuan F; Lin WH; Troyer MD; Tendolkar A; Cutler DL
Eur J Clin Pharmacol; 2013 Oct; 69(10):1761-7. PubMed ID: 23857248
[TBL] [Abstract][Full Text] [Related]
40. Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study.
Graff C; Struijk JJ; Kanters JK; Andersen MP; Toft E; Tyl B
Clin Drug Investig; 2012 May; 32(5):339-51. PubMed ID: 22393898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
